The Barbara Davis Center for Diabetes (BDC) specializes in type 1 diabetes research and care for children and adults. Clinicians, clinical researchers, and basic biomedical scientists collaborate at the BDC to find the most effective treatment, prevention, and cure for type 1 diabetes. The BDC was founded by Marvin and Barbara Davis in 1978 and is currently one of the largest diabetes institutes in the world. Housed in a dedicated building on the Anschutz Medical Campus in Aurora, Colorado, the Center is an independent institute within the University of Colorado School of Medicine.
Learn more about the Barbara Davis Center
Modern biology has been revolutionized by the discovery that many processes of fundamental importance are regulated by RNA molecules. We continue to realize the potential of RNA regulatory mechanisms, illuminating biology and advancing medicine through development of new RNA therapeutics. Major knowledge gaps remain in the basic, diagnostic and therapeutic areas of RNA Bioscience, and much remains to be discovered about mechanisms of RNA regulation and their impact on biology and disease.
The mission of the RNA Bioscience Initiative is to create and expand a vibrant center of discovery and innovation in RNA research, diagnostics and therapy. Our goal is to provide a fluid pipeline from basic to clinical RNA research at the Anschutz Medical Campus.
Learn more about the RNA Bioscience Initiative.
The Gates Center for Regenerative Medicine is a world-class facility located on the Anschutz Medical Campus, the largest new biomedical and clinical campus in the United States. Its first-rate laboratory, as well as its ability to conduct on-site clinical trials has drawn some of the nation’s top talent in stem cell research.
Learn More About the Gates Center
The Colorado Clinical & Translational Sciences Institute (CCTSI) is the academic home to help transform the clinical and translational research and training efforts at the University of Colorado Anschutz Medical Campus and affiliated institutions. The CCTSI was created in 2008 with funding from the Clinical and Translational Science Award (CTSA) initiative of the National Institutes of Health (NIH.)
The University of Colorado School of Medicine is fully equipped with specialized instrumentation and core facilities required to conduct contemporary biomedical investigations. Core facilities include: